An update on the referral pattern of patients with end-stage renal disease

Kidney International, Supplement

Volumn 61, Issue 80, 2002, Pages S27-S34

  Lameire, Norbert ^a,b,c   Wauters, Jean Pierre ^a,b,c   Górriz Teruel, Jose Luis ^a,b,c   Van Biesen, Wim ^a,b,c   Vanholder, Raymond ^a,b,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Dialysis initiation; Patient referral; Pre ESRD care; Vascular access

Indexed keywords

CONFERENCE PAPER; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE QUALITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; NEPHROLOGY; PATIENT CARE; PATIENT REFERRAL; PATIENT SELECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT PLANNING; VASCULAR ACCESS; CHRONIC KIDNEY FAILURE; COST; ECONOMICS; RENAL REPLACEMENT THERAPY; REVIEW; STATISTICS; TIME;

COSTS AND COST ANALYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RENAL DIALYSIS; TIME FACTORS;

EID: 0035999919     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.61.s80.6.x     Document Type: Article

References (65)

1. Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries
2. Renal replacement therapy in the United States: Data from the United States Renal Data System
3. Late referral for maintenance dialysis
4. The timing of referral of patients with end-stage renal disease
5. Early deaths on renal replacement therapy: The need for early nephrological referral
6. Detrimental effects of late referral in patients with chronic renal failure: A case-control study
7. Late referral to maintenance dialysis: Detrimental consequences
8. Significado pronóstico de la diálisis programada en pacientes que inician tratamiento sustitutivo renal. Un estudio multicéntrico español
9. The referral pattern of end-stage renal disease patients and the initiation of dialysis: A European perspective
10. Can we improve early mortality in patients receiving renal replacement therapy?
11. Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis
12. Le transfert tardif au néphrologue pour dialyse chronique: Une pratique en augmentation
13. Late referral of end-stage renal failure
14. Timing of nephrology referral: Influence on mortality and morbidity
15. Early referral and its impact on emergent first dialyses, health care costs, and outcome
16. Community nephrology: Audit of screening for renal insufficiency in a high risk population
17. Screening for renal disease using serum creatinine: Who are we missing?
18. Serum creatinine as an index of renal function: New insights into old concepts
19. Means of clinical evaluation of renal disease progression
20. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate
21. Screening for renal insufficiency: Is it worth while? Is it feasible?
22. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of timedependent changes in GFR
23. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
24. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data
25. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
26. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
27. Insuffisance rénal chronique et pléthore médicale
28. Het verwijzingspatroon in Oost- en West-Vlaanderen van patienten met terminale nierinsufficientie
29. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center
30. Late initiation of dialysis among women and ethnic minorities in the United States
31. Chronic renal failure: Factors influencing nephrology referral
32. Referral for dialysis in Ontario
33. Delayed referral for dialysis
34. Late diagnosis of chronic renal failure and mortality on maintenance dialysis
35. Morbidity and mortality of dialysis
36. Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns
37. European best practice guidelines 1-4: Evaluating anaemia and initiating treatment
38. Chronic kidney disease: Why is current management uncoordinated and suboptimal?
39. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure
40. Modality selection
41. The importance of pre-ESRD education and early nephrological care in peritoneal dialysis selection and outcome
42. Early referral and selection of peritoneal dialysis as a treatment modality
43. FALLER B, ET AL and The European GFR Group: Multicenter study on patient referral to dialysis
44. Treatment modality selection in 150 consecutive patients starting ESRD therapy
45. Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis
46. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings
47. Initiation of dialysis
48. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist
49. At which stage of renal failure should dialysis be started?
50. Urea kinetics and when to commence dialysis
51. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population
52. Clinical practice guidelines for hemodialysis and peritoneal dialysis adequacy
53. Predictors of loss of residual renal function among new dialysis patients
54. When to initiate dialysis: Effect of proposed US guidelines on survival
55. Renal function and nutritional status at the start of chronic dialysis treatment
56. Renal function at initiation of hemodialysis in US and Europe
57. Determinants of type and timing of initial permanent hemodialysis vascular access
58. Timing of nephrology referral predicts vascular access placement prior to ESRD
59. Economic issues, referral patterns, and choice of treatment modality of end-stage renal disease in Europe
60. Timing of nephrologist referral and arteriovenous access use: The CHOICE Study
61. Management of the hemodialysis patient: A European perspective
62. Economic evaluation and the treatment of end-stage renal disease
63. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality
64. End-stage renal disease treatment: A European perspective